MedPath

Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography

Not Applicable
Completed
Conditions
Embolism and Thrombosis of the Radial Artery
Coronary Heart Disease
Registration Number
NCT02324764
Lead Sponsor
Ottawa Heart Institute Research Corporation
Brief Summary

The objective of this study is to determine the rate of radial artery occlusion and vascular access site complications following transradial angiogram using a new Terumo (Tokyo, Japan) Glidesheath Slender, in comparison with the currently used 6 French (6 Fr.) radial sheath.

Detailed Description

Based on previously reported studies the rates of radial artery occlusion using a standard 6 Fr. sheath is around 5-10%, compared to the single feasibility study of the Glidesheath Slender by Aminian et al (see reference in the citations), the rate of radial artery occlusion was reported 0.88%.

This study will be a prospective randomized, single-blinded (patient-blinded) study, comparing the rate of radial artery occlusion and vascular access site complications between the Glidesheath Slender (Terumo, Tokyo, Japan) and the standard 6 Fr. radial sheath in patients undergoing transradial coronary catheterization.

* The study will enroll patients who will undergo elective or emergency coronary angiography and/or percutaneous coronary intervention (PCI) via transradial approach at the University of Ottawa Heart Institute.

* A baseline clinical vascular \& ultrasound assessment will be performed prior to the procedure to document patency of the radial artery.

* Patients will be randomized in 1:1 fashion to either receive the Terumo Glidesheath Slender versus the currently used 6 Fr. sheath.

* The standard angiogram/ PCI will be performed as per usual practice.

* Following the angiogram, clinical vascular assessment as well as an ultrasound will be performed prior to discharge.

* At 30 days follow up the patient will come back for clinical and ultrasound assessment of radial artery patency and access site vascular complications.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Patients undergoing coronary angiography and/or PCI via transradial approach
  • Informed consent
  • Documented normal Allen's test
Exclusion Criteria
  • Patient who had a previous angiogram using the same radial artery
  • Abnormal Allen's test
  • Previous failed radial access.
  • Known bleeding disorder or hypercoagulable condition
  • Cardiogenic shock

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Radial artery occlusion30 days

Evaluated clinically and by ultrasound

Secondary Outcome Measures
NameTimeMethod
Vascular access site complicationsup to 30 days

Includes: Radial artery occlusion, bleeding or hematoma, pseudoaneurysm, artery dissection, compartment syndrome of the forearm

Painful sheath removalparticipants will be followed for the duration of hospital stay, an expected average of 1 day

Scored on a scale of 1-10 scoring system

Sheath kinkingparticipants will be followed for the duration of hospital stay, an expected average of 1 day

Major requiring sheath exchange or minor

Radial artery spasmparticipants will be followed for the duration of hospital stay, an expected average of 1 day
Procedure successparticipants will be followed for the duration of hospital stay, an expected average of 1 day

Defined as ability to finish the angiogram/PCI via the intended access site, without the need to change access site.

Trial Locations

Locations (1)

University of Ottawa Heart Institute

🇨🇦

Ottawa, Ontario, Canada

University of Ottawa Heart Institute
🇨🇦Ottawa, Ontario, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.